top of page

Compliance with FDA's Requirements in Laboratory Controls

Updated: Feb 16


The cGMP regulations emphasize the importance of establishing and documenting laboratory control mechanisms. This includes drafting specifications, standards, sampling plans, test procedures, and other quality control measures. The involvement of the appropriate organizational unit in these processes is crucial to ensure comprehensive and accurate controls. By bringing together expertise from various departments such as manufacturing, quality control, and regulatory affairs, pharmaceutical companies can develop robust laboratory control mechanisms that align with the requirements set forth in Subpart I.  Manufacturing pharmaceutical products requires adherence to stringent regulations to ensure the safety, quality, and efficacy of drugs. One such important regulation is Title 21, Chapter I, Subchapter C, Part 211, commonly known as the Current Good Manufacturing Practice (cGMP) for Finished Pharmaceuticals. This regulation, overseen by the Food and Drug Administration (FDA) under the Department of Health and Human Services, establishes the framework for maintaining laboratory controls in pharmaceutical manufacturing.

The cGMP regulations emphasize the importance of establishing and documenting laboratory control mechanisms. This includes drafting specifications, standards, sampling plans, test procedures, and other quality control measures. The involvement of the appropriate organizational unit in these processes is crucial to ensure comprehensive and accurate controls. By bringing together expertise from various departments such as manufacturing, quality control, and regulatory affairs, pharmaceutical companies can develop robust laboratory control mechanisms that align with the requirements set forth in Subpart I.


Manufacturing pharmaceutical products requires adherence to stringent regulations to ensure the safety, quality, and efficacy of drugs. One such important regulation is Title 21, Chapter I, Subchapter C, Part 211, commonly known as the Current Good Manufacturing Practice (cGMP) for Finished Pharmaceuticals. This regulation, overseen by the Food and Drug Administration (FDA) under the Department of Health and Human Services, establishes the framework for maintaining laboratory controls in pharmaceutical manufacturing.


General Requirements


To comply with the cGMP regulations, it is essential to establish and document various laboratory control mechanisms. Here are some tips to ensure compliance with the general requirements of Subpart I:


a) Organizational Unit Involvement: The appropriate organizational unit, which may include various departments such as manufacturing, quality control, and regulatory affairs, should actively participate in the development of specifications, standards, sampling plans, test procedures, and other laboratory control mechanisms. By involving relevant stakeholders, you can leverage their expertise and ensure the comprehensiveness and accuracy of these controls.

b) Documentation: Documentation is a critical aspect of compliance with cGMP regulations. All requirements specified in Subpart I must be documented at the time of performance. Maintain comprehensive records of specifications, standards, sampling plans, test procedures, and any deviations from these controls, along with justifications for those deviations. Ensure that documentation is readily accessible, well-organized, and regularly reviewed to facilitate effective compliance management.


Laboratory Controls


Laboratory controls play a crucial role in assuring the identity, strength, quality, and purity of components, drug product containers, closures, in-process materials, labeling, and drug products. Here are tips to maintain compliance with laboratory control requirements:


a) Specifications and Sampling: Develop scientifically sound and appropriate specifications, sampling plans, and test procedures for each component, drug product container, closure, in-process material, labeling, and drug product. These specifications should be based on established scientific principles and ensure that products meet the required standards. Additionally, include descriptions of sampling and testing procedures in your specifications to provide clear guidance to personnel involved in the manufacturing process.


When it comes to sampling, ensure that representative samples are obtained from each lot within each shipment of components, drug product containers, closures, and labeling. Properly identify these samples to maintain traceability. Sampling procedures should consider the characteristics of the materials being tested and the potential risks associated with them.


b) In-Process Material Testing: In-process materials are critical intermediates in the pharmaceutical manufacturing process. Establish written specifications and sampling procedures for in-process materials to ensure their quality and conformity to standards. These specifications should align with the intended use of the materials and the requirements of the final drug product. Like other testing procedures, obtain representative samples of in-process materials and ensure they are properly identified for testing purposes.


c) Drug Product Testing: Written descriptions of sampling procedures and appropriate specifications are crucial for drug products. These procedures should define how samples are obtained and what specific tests are conducted to evaluate their quality and conformity to standards. It is essential to use representative samples that accurately reflect the characteristics of the entire batch of drug products. Proper identification of samples helps maintain traceability throughout the manufacturing process.


d) Instrument Calibration: Calibration of instruments, apparatus, gauges, and recording devices is essential to ensure accurate and reliable measurements. Create an established written program for instrument calibration that includes specific directions, schedules, limits for accuracy and precision, and provisions for remedial action if accuracy and/or precision limits are not met. Regularly calibrate and verify the performance of instruments, ensuring compliance with established specifications. Instruments that do not meet calibration specifications should not be used until they are recalibrated or repaired to restore their accuracy and reliability.


Compliance with the FDA's Current Good Manufacturing Practice for Finished Pharmaceuticals is crucial for pharmaceutical manufacturers to ensure the safety and quality of their products. Adhering to the requirements outlined in Subpart I of Part 211 helps maintain robust laboratory controls and promotes consistency in manufacturing processes.


With these comprehensive tips and advice provided, manufacturers can navigate the regulatory landscape effectively and ensure compliance with the cGMP regulations. Remember, compliance is an ongoing commitment, and regular reviews and updates to laboratory controls are essential to stay aligned with the ever-evolving regulatory environment. By prioritizing compliance and implementing robust laboratory control mechanisms, pharmaceutical manufacturers can bolster their reputation, protect consumer health, and contribute to the advancement of the pharmaceutical industry as a whole.


Contact BioBoston Consulting or visit our website to learn more about how we can support your organization.

9 views0 comments

Kommentare

Mit 0 von 5 Sternen bewertet.
Noch keine Ratings

Rating hinzufügen

Subscribe to Our Newsletter

Thanks for submitting!

bottom of page